Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
We are committed to keeping the public informed and will continue to follow the latest clinical trial data, FDA guidance, and regulatory updates surrounding retatrutide and other emerging metabolic therapies
By activating glucagon-like peptide-1 (GLP-1) receptors, retatrutide stimulates insulin secretion from pancreatic beta cells and inhibits glucagon release
Current guidelines recommend stopping semaglutide at least two months before planned conception and tirzepatide at least one month before
see Panel A of Figure 2
US$ 26.24
US$ 28.90
US$ 24.31
US$ 23.93
US$ 22.56
